Medical products distribution is a key component in the healthcare supply chain. Due to the specific requirements relating to the storage and transport of pharmaceutical products, as well as the strict regulations accompanying this activity, it is extremely important to ensure a high level of safety at all stages of transport. This paper-work deals in detail with the identification, analysis and evaluation of safety risks that may arise during the transport and storage of medicinal products with special emphasis on the application of FMEA analysis (failure mode and effects analysis) for the identification of possible errors and their consequences. Three key analyses carried out in the paper-work include: transport route analysis, storage analysis and access control and security analysis in the crossdock warehouse. In the analysis of transport routes, emphasis was placed on technical roadworthiness of vehicles, maintenance of temperature conditions and identification of potential obstacles during transport. Storage analysis deals with storage conditions, such as temperature control and safety of medicines, while access control analysis examines security measures and procedures within transhipment warehouses. All analyses use the FMEA methodology to calculate the number of risk priorities and allow the ranking of risks according to their severity. Risk mitigation strategies have been proposed, including the use of advanced technologies such as GPS, RFID, IoT sensors and geofencing, allowing accurate monitoring and management of safety risk. It pointing-out the need for continuous monitoring and adaptation of safety measures to ensure the high quality of medicines and to protect patients health.